Warberg Asset Management »

Vbi Vaccines shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Vbi Vaccines (VBIV) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Vbi Vaccines

Tip: Access up to 7 years of quarterly data

All positions including Vbi Vaccines held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vbi Vaccines by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.8k 15k 0.59
2023-09-30 $10k 15k 0.67

More positions owned by Warberg Asset Management

Spdr S&p 500 Etf Tr Put Put Option
Occidental Pete Corp W Exp 08/03/202 (OXY.WS)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Invesco Qqq Tr Put Put Option
United States Stl Corp Note 5.000%11/0 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Interdigital Note 2.000% 6/0 (Principal)
Altair Engr Note 0.250% 6/0 (Principal)
Chart Inds Note 1.000%11/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
Hubspot Note 0.375% 6/0 (Principal)
Conmed Corp Note 2.625% 2/0 (Principal)
Repligen Corp Note 0.375% 7/1 (Principal)
RH Note 9/1 (Principal)
Akamai Technologies Note 0.125% 5/0 (Principal)

View all positions for Warberg Asset Management

Top funds holding Vbi Vaccines

Alyeska Investment Group
Perceptive Advisors
Vanguard Group
Cambridge Investment Research Advisors
Citadel Advisors
Goldman Sachs Group
Alpine Partners VI
Two Sigma Securities
Millennium Management
Warberg Asset Management
Captrust Financial Advisors
Steward Partners Investment Advisory
Wetzel Investment Advisors
Royal Bank of Canada
UBS Group

View all funds holding Vbi Vaccines